Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
The NCLT has admitted an insolvency plea under Section 9, affirming unpaid transport invoices as operational debt despite prior settlement default. Shri S. Kangayan has been appointed as Interim Resolution Professional.
The NCLT has admitted a Section 7 plea against SWAL Limited regarding the classification of an inter-corporate loan as financial debt. This development triggers the commencement of Corporate Insolvency Resolution Process (CIRP).
The NCLT admitted an insolvency plea under Section 9 for unpaid transport invoices, classifying them as operational debt.
The Reserve Bank of India has directed regulated entities to implement the updated UNSC sanctions list related to ISIL and Al-Qaida. This mandates strict KYC compliance under Section 51A of the UAPA.
The NCLT directs a ₹24.45 crore repayment with 12% interest following a ruling on fraudulent transactions, emphasizing creditor protection and director accountability in insolvency matters.
The RBI has issued new directions for rural, urban, regional, and local co-operative banks concerning responsible business conduct.
The RBI has modified reporting requirements for authorized persons under FEMA to enhance compliance measures.
The RBI has initiated a review of circulars issued under the Foreign Exchange Management Act, 1999, aiming to streamline regulatory compliance.
The RBI has released new directions for credit derivatives, enhancing regulatory frameworks in this domain.
The Reserve Bank of India has issued guidelines for implementing Section 51A of the UAPA, 1967, addressing updates related to the UN Security Council’s sanctions list for ISIL and Al-Qaida.
New amendments to the Municipal Debt Securities Regulations introduce an ESG-focused framework, promoting transparency and accountability in municipal financing.
The CDSCO's notice regarding the scrutiny of brand name extensions used by pharma companies signals a shift towards regulatory oversight in the pharmaceutical sector. This inquiry may impact how brand identities are managed in compliance with drug regulations.